Table 2 Study outcomes for total depression and anxiety, depression, anxiety and posttraumatic stress symptoms (Intention-To-Treat population)
Outcome | SOLAR-m N = 84* Mean ± SD | Control group N = 78* Mean ± SD | Estimate (95% CI)** (Absolute difference:SOLAR-m minus control) | Cohen’s d Effect Size (95% CI) | p-value |
|---|---|---|---|---|---|
Primary outcome | |||||
Depression and anxiety symptoms (HADS-Total) | |||||
At baseline | 18.0 (6.6) | 18.3 (7.3) | |||
At 8 weeks | 11.6 (6.4) | 14.7 (8.7) | –2.64 (–4.64, –0.63) | –0.33 (–0.59, –0.08) | 0.010 |
At 3-months post follow-up | 12.7 (7.6) | 14.2 (8.5) | –1.70 (–3.59, 0.19) | –0.21 (–0.44, 0.02) | 0.079 |
Secondary outcomes | |||||
Depression symptoms (HADS-Depression) | |||||
At baseline | 7.9 (4.1) | 8.3 (4.3) | |||
At 8 weeks | 4.8 (3.4) | 6.8 (4.9) | –1.51 (–2.72, –0.30) | –0.34 (–0.62, –0.07) | 0.014 |
At 3-months post follow-up | 5.4 (4.4) | 6.7 (4.9) | –1.32 (–2.49, –0.15) | –0.28 (–0.53, –0.03) | 0.027 |
Anxiety symptoms (HADS-Anxiety) | |||||
At baseline | 10.1 (3.5) | 10.0 (3.8) | |||
At 8 weeks | 6.7 (3.5) | 7.9 (4.4) | –1.18 (–2.23, –0.13) | –0.30 (–0.56, –0.03) | 0.028 |
At 3-months post follow-up | 7.4 (4.0) | 7.6 (4.2) | –0.36 (–1.38, 0.67) | –0.09 (–0.34, 0.16) | 0.491 |
Posttraumatic stress symptoms (PCL-5) | |||||
At baseline | 29.7 (15.3) | 31.5 (18.2) | |||
At 8 weeks | 18.5 (10.7) | 26.1 (19.2) | –5.17 (–8.51, –1.83) | –0.32 (–0.52, –0.11) | 0.002 |
At 3-months post follow-up | 21.5 (15.0) | 23.7 (16.4) | –2.26 (–5.52, 1.01) | –0.14 (–0.35, 0.06) | 0.175 |
